|
81 |
Rekonstruktionsmöglichkeiten des Harnleiters
Enthalten in Der Urologe / Ausgabe A Bd. 58, 16.5.2019, Nr. 6, date:6.2019: 651-657
|
|
|
|
82 |
Robot-assisted radical cystectomy and intracorporeal neobladder formation: on the way to a standardized procedure
Enthalten in World journal of surgical oncology Bd. 13, 6.1.2015, Nr. 1, date:12.2015: 1-6
|
|
|
|
83 |
Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines
Enthalten in International archives of occupational and environmental health Bd. 87, 16.10.2013, Nr. 7, date:10.2014: 715-724
|
|
|
|
84 |
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
Enthalten in Journal for ImmunoTherapy of Cancer Bd. 3, 16.6.2015, Nr. 1, date:12.2015: 1-14
|
|
|
|
85 |
Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma
Enthalten in BMC urology Bd. 12, 21.3.2012, Nr. 1, date:12.2012: 1-7
|
|
|
|
86 |
SIU–ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer
Enthalten in World journal of urology Bd. 37, 25.1.2019, Nr. 1, date:1.2019: 61-83
|
|
|
|
87 |
T2 mapping for the characterization of prostate lesions
Enthalten in World journal of urology Bd. 40, 31.3.2022, Nr. 6, date:6.2022: 1455-1461
|
|
|
|
88 |
The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer
Enthalten in World journal of urology Bd. 34, 29.9.2015, Nr. 6, date:6.2016: 829-834
|
|
|
|
89 |
The Value and Evaluability of the PCA3 Urine Assay in Prostate Carcinoma is Independent of the Tumor Localization
Enthalten in Advances in therapy Bd. 34, 13.3.2017, Nr. 4, date:4.2017: 966-974
|
|
|
|
90 |
TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification
Enthalten in Nature Communications Bd. 14, 17.11.2023, Nr. 1, date:12.2023: 1-12
|
|
Administration
